INTRODUCTION: In preparation for the introduction of a rotavirus vaccine into the routine immunization program of Bangladesh in 2018, we report data and highlight evolving genotypes from five years of active hospital-based rotavirus surveillance which began in July 2012. METHODS: We enrolled and collected fresh stool from every fourth child < 5 years admitted with acute gastroenteritis (AGE) at 8 participating surveillance hospitals. Rotavirus infections were detected by enzyme immune assay. Twenty-five percent of rotavirus isolates were genotyped using reverse transcription polymerase chain reaction. RESULTS: We found that 64% (4832/7562) of children < 5 years of age admitted with AGE had evidence of rotavirus infection. The majority (57%) of patients with rotavirus infection were <12 months of age. The most common strains were G1P[8] (43%), G12P[8] (15%) and G9P[8] (9%); 11% of children had mixed infection.G3P[8], which has not been reported in Bangladesh since 2001, was documented for the first time in our surveillance system. CONCLUSIONS: The high burden of rotavirus-associated hospitalizations highlights the potential value of rotavirus vaccination in Bangladesh. Continued surveillance is important for monitoring the impact of vaccination as well as monitoring evolving genotypes.
INTRODUCTION: In preparation for the introduction of a rotavirus vaccine into the routine immunization program of Bangladesh in 2018, we report data and highlight evolving genotypes from five years of active hospital-based rotavirus surveillance which began in July 2012. METHODS: We enrolled and collected fresh stool from every fourth child < 5 years admitted with acute gastroenteritis (AGE) at 8 participating surveillance hospitals. Rotavirus infections were detected by enzyme immune assay. Twenty-five percent of rotavirus isolates were genotyped using reverse transcription polymerase chain reaction. RESULTS: We found that 64% (4832/7562) of children < 5 years of age admitted with AGE had evidence of rotavirus infection. The majority (57%) of patients with rotavirus infection were <12 months of age. The most common strains were G1P[8] (43%), G12P[8] (15%) and G9P[8] (9%); 11% of children had mixed infection.G3P[8], which has not been reported in Bangladesh since 2001, was documented for the first time in our surveillance system. CONCLUSIONS: The high burden of rotavirus-associated hospitalizations highlights the potential value of rotavirus vaccination in Bangladesh. Continued surveillance is important for monitoring the impact of vaccination as well as monitoring evolving genotypes.
Authors: Leslie A Enane; Paul A Gastañaduy; David M Goldfarb; Jeffrey M Pernica; Margaret Mokomane; Banno Moorad; Lingani Masole; Jacqueline E Tate; Umesh D Parashar; Andrew P Steenhoff Journal: Clin Infect Dis Date: 2016-05-01 Impact factor: 9.079
Authors: Mustafizur Rahman; Rasheda Sultana; Giasuddin Ahmed; Sharifun Nahar; Zahid M Hassan; Farjana Saiada; Goutam Podder; Abu S G Faruque; A K Siddique; David A Sack; Jelle Matthijnssens; Marc Van Ranst; Tasnim Azim Journal: Emerg Infect Dis Date: 2007-01 Impact factor: 6.883
Authors: Syed M Satter; Paul A Gastanaduy; Khaleda Islam; Mahmudur Rahman; Mustafizur Rahman; Stephen P Luby; James D Heffelfinger; Umesh D Parashar; Emily S Gurley Journal: Pediatr Infect Dis J Date: 2017-02 Impact factor: 2.129
Authors: Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass Journal: Emerg Infect Dis Date: 2003-05 Impact factor: 6.883
Authors: Syed M Satter; Zarin Abdullah; Cristina V Cardemil; Meerjady S Flora; Emily S Gurley; Mahmudur Rahman; Muhammad Talha; Md D Islam; Mohammad E Hossain; Neha Balachandran; Benjamin Lopman; Mustafizur Rahman; Jan Vinjé; Aron J Hall; Umesh D Parashar Journal: Pediatr Infect Dis J Date: 2021-03-01 Impact factor: 3.806
Authors: Lauren M Schwartz; K Zaman; Md Yunus; Ahasan-Ul H Basunia; Abu Syed Golam Faruque; Tahmeed Ahmed; Mustafizur Rahman; Jonathan D Sugimoto; M Elizabeth Halloran; Ali Rowhani-Rahbar; Kathleen M Neuzil; John C Victor Journal: Clin Infect Dis Date: 2019-11-27 Impact factor: 9.079
Authors: Adam L Cohen; Negar Aliabadi; Fatima Serhan; Jacqueline E Tate; Patrick Zuber; Umesh D Parashar Journal: Vaccine Date: 2018-08-18 Impact factor: 4.169
Authors: R Mazid; M S Aung; S K Paul; F U Ahmad; M Alam; M A Ali; P Nath; S Ahmed; N Haque; M A Hossain; N Kobayashi Journal: New Microbes New Infect Date: 2019-11-26